Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,337,747
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
66,466,915
-
Shares change
-
+2,075,698
-
Total reported value, excl. options
-
$594,208,237
-
Value change
-
+$17,736,112
-
Put/Call ratio
-
200%
-
Number of buys
-
53
-
Number of sells
-
-29
-
Price
-
$8.94
Significant Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) as of Q4 2022
105 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,466,915 shares
of 105,337,747 outstanding shares and own 63% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (14,567,176 shares), FMR LLC (8,589,229 shares), Novo Holdings A/S (6,071,703 shares), VIKING GLOBAL INVESTORS LP (4,409,146 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3,933,137 shares), EcoR1 Capital, LLC (3,493,194 shares), Deep Track Capital, LP (3,374,394 shares), Cormorant Asset Management, LP (2,946,887 shares), BlackRock Inc. (2,873,624 shares), and CITADEL ADVISORS LLC (2,846,519 shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.